|
US20080220025A1
(en)
*
|
1995-03-17 |
2008-09-11 |
James Thompson |
Treating Tumors Using Implants Comprising Combinations of Allogeneic Cells
|
|
US7361332B2
(en)
*
|
1995-03-17 |
2008-04-22 |
The Regents Of The University Of California |
Treating tumors using implants comprising combinations of allogeneic cells
|
|
AU7154598A
(en)
*
|
1997-04-23 |
1998-11-13 |
Regents Of The University Of California, The |
A cell strain with activated anti-cancer cytotoxic activity
|
|
AU9794698A
(en)
|
1997-10-10 |
1999-05-03 |
Regents Of The University Of California, The |
Enhanced immunogenic cell populations prepared using h2 receptor antagonists
|
|
EP1037643B1
(en)
|
1997-10-10 |
2003-12-03 |
Meyer Pharmaceuticals, LLC |
Cancer immunotherapy using allostimulated cells in a multiple sequential implantation strategy
|
|
EP1021197B1
(en)
|
1997-10-10 |
2007-04-11 |
The Regents of the University of California |
Implants comprising combinations of allogeneic cells for use in cancer treatment
|
|
JP4389039B2
(ja)
*
|
1998-04-09 |
2009-12-24 |
株式会社リンフォテック |
アロジェニックな活性化ｃｄ４陽性細胞を主成分とする医薬組成物、およびその製造方法、ならびに該医薬組成物調製用キット
|
|
US7666609B1
(en)
|
1998-12-01 |
2010-02-23 |
Shanghai Cp Guojian Pharmaceutical Co. Ltd. |
Method and composition for diagnosis of melanocytic lesions
|
|
CA2362578A1
(en)
|
1999-02-09 |
2000-08-17 |
Kam Leong |
Tumor vaccines
|
|
DE60144515D1
(de)
|
2000-04-01 |
2011-06-09 |
Onyvax Ltd |
Prostata zellinien und deren verwendung
|
|
US20080194022A1
(en)
*
|
2000-08-03 |
2008-08-14 |
Clarke Michael F |
Isolation and use of solid tumor stem cells
|
|
US6984522B2
(en)
*
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
|
DE10043437A1
(de)
*
|
2000-09-04 |
2002-03-28 |
Horst Lindhofer |
Verwendung von trifunktionellen bispezifischen und trispezifischen Antikörpern zur Behandlung von malignem Aszites
|
|
US7723111B2
(en)
*
|
2001-03-09 |
2010-05-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Activated dual specificity lymphocytes and their methods of use
|
|
HUP0400882A3
(en)
*
|
2001-05-11 |
2011-01-28 |
Wellstat Biologics Corp |
Oncolytic virus therapy
|
|
US7658926B2
(en)
*
|
2001-09-14 |
2010-02-09 |
Opexa Pharmaceuticals, Inc. |
Autologous T-cell vaccines materials and methods
|
|
EP1293205A1
(en)
*
|
2001-09-18 |
2003-03-19 |
G2M Cancer Drugs AG |
Valproic acid and derivatives thereof for the combination therapy of human cancers, for the treatment of tumour metastasis and minimal residual disease
|
|
EP1451332B1
(en)
*
|
2001-11-27 |
2008-02-13 |
neXyte AB |
Production of eukaryotic proteins and nucleic acid molecules in c. elegans
|
|
KR20020060643A
(ko)
*
|
2002-06-04 |
2002-07-18 |
김진경 |
타인의 면역시스템을 이용하는 암의 치료 방법
|
|
WO2004015070A2
(en)
*
|
2002-08-08 |
2004-02-19 |
Baylor College Of Medicine |
Isolation and identification of t cells
|
|
US7571817B2
(en)
*
|
2002-11-06 |
2009-08-11 |
Varco I/P, Inc. |
Automatic separator or shaker with electromagnetic vibrator apparatus
|
|
WO2004075855A2
(en)
|
2003-02-26 |
2004-09-10 |
Biomed Solutions, Llc |
Process for in vivo treatment of specific biological targets in bodily fluid
|
|
KR20040094635A
(ko)
*
|
2003-05-02 |
2004-11-10 |
주식회사 엠디바이오알파 |
항종양 활성의 유도를 위한 종양 백신의 제조방법 및그것을 함유하고 있는 약제 조성물
|
|
US7811983B2
(en)
*
|
2003-06-11 |
2010-10-12 |
The University Of Chicago |
Increased T-cell tumor infiltration and eradication of metastases by mutant light
|
|
WO2005002628A1
(en)
|
2003-06-11 |
2005-01-13 |
The University Of Chicago |
Increased t-cell tumor infiltration by mutant light
|
|
US20050019336A1
(en)
|
2003-07-23 |
2005-01-27 |
Dalgleish Angus George |
Human prostate cell lines in cancer treatment
|
|
US7696322B2
(en)
*
|
2003-07-28 |
2010-04-13 |
Catalent Pharma Solutions, Inc. |
Fusion antibodies
|
|
JP2007508018A
(ja)
*
|
2003-10-08 |
2007-04-05 |
べト−ステム インコーポレイテッド |
新規の幹細胞組成物の調製法および使用法、ならびにこの組成物を含有するキット
|
|
US8029454B2
(en)
|
2003-11-05 |
2011-10-04 |
Baxter International Inc. |
High convection home hemodialysis/hemofiltration and sorbent system
|
|
US20050112684A1
(en)
*
|
2003-11-21 |
2005-05-26 |
Eric Holzle |
Class I and Class II MHC Profiling for Social and Sexual Matching of Human Partners
|
|
EP2369014A1
(en)
|
2004-02-03 |
2011-09-28 |
The Regents Of The University Of Michigan Office Of Technology Transfer |
Compositions and methods for characterizing, regulating, diagnosing and treating cancer
|
|
US7858323B2
(en)
|
2004-06-09 |
2010-12-28 |
The Regents Of The University Of Michigan |
Phage microarray profiling of the humoral response to disease
|
|
US8257715B1
(en)
|
2004-08-26 |
2012-09-04 |
University Of Notre Dame |
Tissue vaccines and uses thereof
|
|
US9155789B2
(en)
*
|
2005-04-25 |
2015-10-13 |
New York University |
Use of allogenic or syngenic major histocompatibility complex (MHC) molecules as universal adjuvants for vaccines against neoplastic disease, infection and autoimmune disease
|
|
US20090162405A1
(en)
*
|
2006-12-14 |
2009-06-25 |
Yong Qian |
Proteinase-engineered cancer vaccine induces immune responses to prevent cancer and to systemically kill cancer cells
|
|
US8778362B2
(en)
|
2005-10-27 |
2014-07-15 |
University Of Notre Dame |
Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof
|
|
US8802113B2
(en)
*
|
2005-10-27 |
2014-08-12 |
University Of Notre Dame |
Extracellular matrix cancer vaccine adjuvant
|
|
US8778360B2
(en)
*
|
2005-10-27 |
2014-07-15 |
University Of Notre Dame |
Extracellular matrix cancer vaccine adjuvant
|
|
US9308252B2
(en)
*
|
2005-10-27 |
2016-04-12 |
Cook Biotech, Inc. |
Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
|
|
CA2628221A1
(en)
|
2005-10-31 |
2007-05-10 |
Oncomed Pharmaceuticals, Inc. |
Anti-frizzled receptor antibodies for treating cancer
|
|
CA2628255C
(en)
*
|
2005-10-31 |
2016-04-19 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
|
WO2007100640A2
(en)
*
|
2006-02-21 |
2007-09-07 |
The Regents Of The University Of Michigan |
Growth hormone receptor antagonist cancer treatment
|
|
US20080019961A1
(en)
*
|
2006-02-21 |
2008-01-24 |
Regents Of The University Of Michigan |
Hedgehog signaling pathway antagonist cancer treatment
|
|
PT2016414E
(pt)
*
|
2006-05-05 |
2015-11-24 |
Opexa Therapeutics |
Vacina de células t
|
|
US8350011B2
(en)
|
2006-08-04 |
2013-01-08 |
Medimmune Limited |
Antibodies to ErbB2
|
|
US7972594B2
(en)
*
|
2006-11-13 |
2011-07-05 |
Immunovative Therapies Ltd. |
Ablative immunotherapy
|
|
US8691568B2
(en)
*
|
2006-11-22 |
2014-04-08 |
Hua Liu |
Method for preparing cell populations with anti-tumor immune response activity
|
|
US20080147007A1
(en)
*
|
2006-12-19 |
2008-06-19 |
Toby Freyman |
Delivery device with pressure control
|
|
WO2008092002A2
(en)
|
2007-01-24 |
2008-07-31 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
|
CN101641010A
(zh)
|
2007-01-26 |
2010-02-03 |
路易斯维尔大学研究基金会公司 |
用作疫苗的外来体组分的修饰
|
|
US20090093429A1
(en)
*
|
2007-02-08 |
2009-04-09 |
Yang-Xin Fu |
Combination therapy for treating cancer
|
|
EP2160200B1
(en)
|
2007-05-14 |
2013-07-10 |
The University of Chicago |
Antibody-LIGHT fusion products as cancer therapeutics
|
|
US8741315B2
(en)
*
|
2007-09-12 |
2014-06-03 |
Yeda Research And Development Co. Ltd. |
Methods of treating tumors in immune-privileged sites
|
|
US8114276B2
(en)
|
2007-10-24 |
2012-02-14 |
Baxter International Inc. |
Personal hemodialysis system
|
|
US9283266B2
(en)
*
|
2008-02-28 |
2016-03-15 |
University Of Notre Dame |
Metastasis inhibition preparations and methods
|
|
SG190568A1
(en)
|
2008-09-26 |
2013-06-28 |
Oncomed Pharm Inc |
Frizzled-binding agents and uses thereof
|
|
WO2010051502A2
(en)
*
|
2008-10-31 |
2010-05-06 |
Biogen Idec Ma Inc. |
Light targeting molecules and uses thereof
|
|
KR20110093893A
(ko)
|
2008-11-11 |
2011-08-18 |
더 리젠츠 오브 더 유니버시티 오브 미시간 |
항-ｃｘｃｒ１ 조성물 및 방법
|
|
CU23740A1
(es)
*
|
2009-09-29 |
2011-12-28 |
Ct Ingenieria Genetica Biotech |
Método de obtención de una formulación de antígenos del virus de la hepatitis b
|
|
EP2494038B1
(en)
*
|
2009-10-27 |
2019-06-26 |
Immunicum AB |
Method for proliferation of antigen-specific t cells
|
|
AU2010341703B2
(en)
*
|
2009-12-08 |
2016-01-21 |
The Board Of Trustees Of The University Of Illinois |
Stem cell immune modulation methods of use and apparatus
|
|
US8846059B2
(en)
|
2009-12-08 |
2014-09-30 |
University Of Notre Dame |
Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer
|
|
US20110150934A1
(en)
*
|
2009-12-18 |
2011-06-23 |
University Of Notre Dame |
Ovarian Tumor Tissue Cell Preparations/Vaccines for the Treatment/Inhibition of Ovarian Tumors and Ovarian Cancer
|
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Ｗｎｔ拮抗劑及治療和篩選方法
|
|
US20110237461A1
(en)
|
2010-03-17 |
2011-09-29 |
The Regents Of The University Of Michigan |
Using phage epitopes to profile the immune response
|
|
CA2794674A1
(en)
|
2010-04-01 |
2011-10-06 |
Oncomed Pharmaceuticals, Inc. |
Frizzled-binding agents and uses thereof
|
|
KR20130055591A
(ko)
*
|
2010-04-13 |
2013-05-28 |
가부시키가이샤 르네상스 에너지 인베스트먼트 |
암 조직 유래 세포괴 또는 암 세포 응집괴로부터 얻어지는 암 치료용 조성물과 그것을 이용한 면역요법제의 제조 방법 및 면역요법 효과 평가 방법
|
|
WO2012151266A1
(en)
|
2011-05-03 |
2012-11-08 |
Michael Har-Noy |
Methods for handling biological drugs containing living cells
|
|
PL3892295T3
(pl)
*
|
2011-05-24 |
2023-07-24 |
BioNTech SE |
Zindywidualizowane szczepionki przeciwnowotworowe
|
|
CA2858876A1
(en)
|
2011-12-15 |
2013-06-20 |
The University Of Chicago |
Methods and compositions for cancer therapy using mutant light molecules with increased affinity to receptors
|
|
AU2013334790A1
(en)
|
2012-10-23 |
2015-04-30 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating neuroendocrine tumors using Wnt pathway-binding agents
|
|
AU2014212081A1
(en)
|
2013-02-04 |
2015-08-13 |
Oncomed Pharmaceuticals, Inc. |
Methods and monitoring of treatment with a Wnt pathway inhibitor
|
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
|
CN105873639A
(zh)
*
|
2013-09-27 |
2016-08-17 |
万科斯诺晋国际合作有限公司 |
自体肿瘤疫苗和方法
|
|
AU2015343239B2
(en)
|
2014-11-05 |
2021-06-03 |
Memorial Sloan Kettering Cancer Center |
Methods of selecting T cell line and donor thereof for adoptive cellular therapy
|
|
US20180055920A1
(en)
*
|
2015-03-12 |
2018-03-01 |
University Of Iowa Research Foundation |
Vaccine, therapeutic composition and methods for treating or inhibiting cancer
|
|
WO2016209816A1
(en)
*
|
2015-06-26 |
2016-12-29 |
Memorial Sloan Kettering Cancer Center |
Methods of treating cmv retinitis by t cell therapy
|
|
GB2592821B
(en)
|
2015-07-31 |
2022-01-12 |
Univ Minnesota |
Modified cells and methods of therapy
|
|
WO2017087784A1
(en)
|
2015-11-18 |
2017-05-26 |
Duke University |
Tumor infiltrating lymphocytes for treatment of cancer
|
|
CN110520530A
(zh)
|
2016-10-18 |
2019-11-29 |
明尼苏达大学董事会 |
肿瘤浸润性淋巴细胞和治疗方法
|
|
WO2018138682A1
(en)
|
2017-01-26 |
2018-08-02 |
Immune Therapeutics |
Methods and compositions useful for treating cancer
|
|
WO2018224166A1
(en)
|
2017-06-09 |
2018-12-13 |
Biontech Rna Pharmaceuticals Gmbh |
Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy
|
|
EP3645021A4
(en)
|
2017-06-30 |
2021-04-21 |
Intima Bioscience, Inc. |
ADENO-ASSOCIATED VIRAL VECTORS FOR GENE THERAPY
|
|
KR102256337B1
(ko)
*
|
2017-10-17 |
2021-05-26 |
(주)노터스생명과학 |
조직이식을 위한 세포배양액을 포함하는 면역억제제
|
|
US11446329B2
(en)
|
2017-11-01 |
2022-09-20 |
Restem Llc |
Natural killer cell adoptive transfer therapy for the elimination of senescent PBMCs, reduction of inflammatory cytokines and treatment of IBS
|
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neoantigens
|
|
FR3082730B1
(fr)
|
2018-06-21 |
2022-04-22 |
Med Inn Pharma |
Methode de resolution de l'inflammation pro-tumorale a l'aide d'une preparation pharmaceutique
|
|
WO2023196232A1
(en)
*
|
2022-04-04 |
2023-10-12 |
University Of Florida Research Foundation, Inc. |
Method of characterizing tumors
|
|
CN114984199A
(zh)
*
|
2022-04-19 |
2022-09-02 |
苏州尔生生物医药有限公司 |
一种基于癌症特异性t细胞的细胞系统、淋巴细胞药物及其应用
|